Bristol-Myers Squibb filed Form 13F with the Securities and Exchange Commission on August 25, 2026.

The entities involved

• Bristol-Myers Squibb →

  American pharmaceutical company

  • Pfizer, J&J, BMS, Sanofi, and AbbVie are leading innovation in personalized therapies and are key players in the multiple myeloma treatment market.14:49
  • BMS, Eli Lilly, and Novo Nordisk are advancing GLP-1 portfolios, investing in manufacturing, and navigating regulatory approvals.13:45
• Securities and Exchange Commission →

  government agency of the Philippines

  • Company disclosed insider trades in an SEC filing on October 22, 2026.21:50
  • Dangote Group is behind the refinery's IPO, and the Securities and Exchange Commission is monitoring the promotion of the shares.16:22

Related events

• AerCap filed its required Form 13F disclosures with the Securities and Exchange Commission.Jul 18
• NewLake Capital Partners, Inc. filed Form 13F with the Securities and Exchange Commission.Wed 22:11
• Wealth Enhancement Trust Services Inc. filed Form 13F with the Securities and Exchange Commission on October 7, 2026.Oct 8
• Vontobel filed Form 13F with the Securities and Exchange Commission on October 20, 2026.Tue 10:09
• Citadel Advisors LLC bought a new stake in Baird Medical Investment Holdings Limited and filed a 13F with the SEC.Oct 10